bioAffinity Technologies, Inc. Profile Avatar - Palmy Investing

bioAffinity Technologies, Inc.

bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targe…

Medical - Diagnostics & Research
US, San Antonio [HQ]

Document Reader

Click To Read:

DEF 14-A Proxies

Not a single DEF 14-A proxy doc.

10-K Filings

Not a single 10-K doc.

10-Q Filings

Not a single 10-Q doc.

LDA 1/2 Filings [Lobbying]

Not a single LDA doc.

End of BIAF's Analysis
CIK: 1712762 CUSIP: 09076W109 ISIN: US09076W1099 LEI: - UEI: -
Secondary Listings
BIAF has no secondary listings inside our databases.